Session Chair
Chris Cabell
Duke University
Durham NC USA |
Session Co-Chair
Elias Mallis
USFDA
Rockville MD USA |
| Time |
Speaker/Topic |
| 0830 - 0835 |
Chris Cabell, Duke University, Durham NC USA Overview |
| 0835 - 0850 |
Fabio Badilini, AAMPS - LLC, Montichiari ITALY
The Use of ECGs in Interval Measurements and Automated Diagnostic Algorithms: Derived Ecgs, Lead Positions, and Representative Beats
|
| 0850 - 0905 |
Discussion |
| 0905 - 0920 |
Justin Mortara, Mortara Instrument, Inc., Milwaukee
WI USA Fidelity of Waveform Definition from 128 Hz to 1000Hz: Does It Make a Difference?
|
| 0920 - 0935 |
Discussion |
| 0935 - 0950 |
Chris Cabell, Duke University, Durham NC USA
The Use of ECG Algorithms in Clinical Care and Clinical Trials: The Balance between Machine and Human Interpretation?
|
| 0950 - 1005 |
Discussion |
| 1005 - 1030 |
BREAK |
| 1030 - 1045 |
Barbara Drew, UCSF, San Francisco CA USA
Novel ECG Configurations and Transmission Procedures: The Effect
on Ischemia and Arrhythmia Determination
|
| 1045 - 1100 |
Discussion |
| 1100 - 1115 |
Robert Lux, University of Utah, Salt Lake City UT USA
Understanding Pro-Arrhythmogenic Potential in Therapeutic Drug
Development: Alternate Strategies for Detection and Monitoring of
Arrhythmic Episodes |
| 1115 - 1130 |
Discussion |
| 1130 - 1145 |
Linda Shoemaker, USFDA, Rockville MD USA What is an ECG? The FDA Perspective |
| 1145 - 1200 |
Discussion |